| abstract |
The use of ribavirin is described for the manufacture of compositions for modulating lymphokine expression in activated T cells of a human patient. Further described is the use of ribavirin for the manufacture of a composition for the treatment of non-viral diseases such as allergy, autoimmune disease or helminthosis, and for the treatment of non-viral proportions of diseases having viral and non-viral proportions. |